Advances in organ preservation techniques and future prospects

A review article published in Engineering delves into the crucial field of organ preservation, exploring its history, current techniques, and future prospects.

TG Therapeutics signs $645M deal to kick-start international launch of MS antibody

TG Therapeutics is looking to expand access to its CD20 antibody Briumvi outside North America and has announced a partnership with the European pharma company

August 2, 2023

Transgender women face significantly more injuries than cisgender women

A new study found that injury rates among transgender women are significantly higher than injuries among cisgender women, based on radiological imaging.

December 4, 2024

DEFENCE RECEIVES FDA APPROVAL FOR PHASE I CLINICAL TRIAL TARGETING SOLID CANCER TUMORS WITH ACCUTOX® – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE RECEIVES FDA APPROVAL FOR PHASE I CLINICAL TRIAL TARGETING SOLID CANCER TUMORS WITH ACCUTOX® 12.12.2023 /

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.